Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.

The Big Blue Test is a program of the Diabetes Hands Foundation that rallies communities to experience the impact that small changes can have on their health.

Dexcom, Inc. headquartered in San Diego, CA, is developing and marketing continuous glucose monitoring systems for ambulatory use by people with diabetes and by healthcare providers in the hospital.

The Dexcom One Step Ahead Foundation: A Dexcom Employees Foundation works to support the missions and purposes of tax-exempt organizations that provide services and programs to people living with diabetes and their caregivers in the United States.  Run by its own Board of Directors, comprising Dexcom employees and external participants, the Foundation will provide monetary grants to organizations designated by the IRS as 501(c)3 Public Charities so that these organizations can assist people living with diabetes – as well as their caregivers – to better understand their medical condition, to manage their diabetes more effectively, and to live healthier lifestyles.

Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod® Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes.

Who is Janssen? We’re more than 30,000 people working hard to prevent, treat, cure and stop some of the most devastating and complex diseases of our time. From heart disease to HIV, Alzheimer’s disease to cancer, we are committed to issues that touch everyone’s lives.

We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.” More than 140 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.

Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries. 

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs.  Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, huan vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.  

Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integratedapproach to the design, development and commercialization of products for people with insulin-dependent diabetes.